DK0648116T3 - Sammensætning til kontrolleret frigivelse af et aktivt stof og fremgangsmåde til fremstilling af sådan en sammensætning - Google Patents

Sammensætning til kontrolleret frigivelse af et aktivt stof og fremgangsmåde til fremstilling af sådan en sammensætning

Info

Publication number
DK0648116T3
DK0648116T3 DK93916292.1T DK93916292T DK0648116T3 DK 0648116 T3 DK0648116 T3 DK 0648116T3 DK 93916292 T DK93916292 T DK 93916292T DK 0648116 T3 DK0648116 T3 DK 0648116T3
Authority
DK
Denmark
Prior art keywords
active substance
composition
pct
preparing
controlled release
Prior art date
Application number
DK93916292.1T
Other languages
Danish (da)
English (en)
Inventor
Arie Cornelis Besemer
Coenraad Ferdinand Lerk
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of DK0648116T3 publication Critical patent/DK0648116T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK93916292.1T 1992-07-03 1993-07-02 Sammensætning til kontrolleret frigivelse af et aktivt stof og fremgangsmåde til fremstilling af sådan en sammensætning DK0648116T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9201195A NL9201195A (nl) 1992-07-03 1992-07-03 Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.

Publications (1)

Publication Number Publication Date
DK0648116T3 true DK0648116T3 (da) 1997-03-24

Family

ID=19861014

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93916292.1T DK0648116T3 (da) 1992-07-03 1993-07-02 Sammensætning til kontrolleret frigivelse af et aktivt stof og fremgangsmåde til fremstilling af sådan en sammensætning

Country Status (12)

Country Link
US (1) US5585114A (fr)
EP (1) EP0648116B1 (fr)
JP (1) JPH07508533A (fr)
AT (1) ATE143801T1 (fr)
AU (1) AU678166B2 (fr)
CA (1) CA2139494A1 (fr)
DE (1) DE69305346T2 (fr)
DK (1) DK0648116T3 (fr)
ES (1) ES2095658T3 (fr)
GR (1) GR3022195T3 (fr)
NL (1) NL9201195A (fr)
WO (1) WO1994001092A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401572A (nl) * 1994-09-27 1996-05-01 Avebe Coop Verkoop Prod Zetmeelprodukten als tabletteerhulpstof, werkwijze voor het bereiden daarvan alsmede werkwijze voor het maken van tabletten.
FR2743496B1 (fr) * 1996-01-15 1998-04-10 Univ Rennes Composite macroporeux support de substance(s) medicamenteuse(s) utilisable comme materiau de reconstitution osseuse et procede d'elaboration
GB9605857D0 (en) * 1996-03-20 1996-05-22 Tester Richard F Polysaccharides as chemical release systems
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
CA2211778A1 (fr) * 1997-08-14 1999-02-14 Francois Carriere Preparation d'un amidon riche en amylose pregelatinise et deramifie utile comme excipient pour la liberation prolongee de principes actifs
WO1999030691A2 (fr) * 1997-12-18 1999-06-24 Ato B.V. Composition permettant de reguler la liberation de composes actifs
JP2004529902A (ja) 2001-03-13 2004-09-30 ペンウェスト ファーマシューティカルズ カンパニー グルココルチコステロイドを含有する時間治療（ｃｈｒｏｎｏｔｈｅｒａｐｅｕｔｉｃ）投与形態
JP3742335B2 (ja) * 2001-12-20 2006-02-01 富士通株式会社 入出力バッファ回路
US7081261B2 (en) * 2002-05-14 2006-07-25 National Starch And Chemical Investment Holding Corporation Resistant starch prepared by isoamylase debranching of low amylose starch
US6890571B2 (en) * 2002-05-14 2005-05-10 National Starch And Chemical Investment Holding Corporation Slowly digestible starch product
US6929817B2 (en) * 2002-05-14 2005-08-16 National Starch & Chemical Investment Holding Corporation Slowly digestible starch product
US20040185097A1 (en) * 2003-01-31 2004-09-23 Glenmark Pharmaceuticals Ltd. Controlled release modifying complex and pharmaceutical compositions thereof
CN1823091B (zh) 2003-07-11 2010-05-12 旭化成化学株式会社 功能性淀粉粉末
US20070071810A1 (en) * 2003-08-26 2007-03-29 Kenichi Kudo Additive for tablets
KR100782918B1 (ko) 2003-09-19 2007-12-07 펜웨스트 파머슈티칼즈 컴파니 지연 방출성 제형
EP1957123B1 (fr) 2005-12-09 2015-07-29 Sca Hygiene Products Ab Produit absorbant
RU2519715C2 (ru) * 2008-10-23 2014-06-20 Хенкель Корпорейшн Фармацевтические гранулы, содержащие модифицированный крахмал, и их терапевтические применения
US20130172411A1 (en) * 2010-03-22 2013-07-04 Cadila Healthcare Limited Stable pharmaceutical compositions comprising fesoterodine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
GB1072795A (en) * 1963-08-28 1967-06-21 Eastman Kodak Co Solid composition containing fat-soluble vitamins and processes for making it
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
WO1985003414A1 (fr) * 1984-01-31 1985-08-15 Scm Corporation Composition de matrice d'encapsulage et produit encapsule la contenant
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
JPH0747539B2 (ja) * 1986-10-22 1995-05-24 東京田辺製薬株式会社 胆汁酸固形製剤
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
CA2041774C (fr) * 1990-11-27 1994-04-19 Mircea A. Mateescu Utilisation d'amylose reticulee en tant que matrice pour la liberation lente de composes biologiquement actifs

Also Published As

Publication number Publication date
ATE143801T1 (de) 1996-10-15
EP0648116A1 (fr) 1995-04-19
GR3022195T3 (en) 1997-03-31
JPH07508533A (ja) 1995-09-21
DE69305346D1 (de) 1996-11-14
NL9201195A (nl) 1994-02-01
ES2095658T3 (es) 1997-02-16
CA2139494A1 (fr) 1994-01-20
WO1994001092A1 (fr) 1994-01-20
AU678166B2 (en) 1997-05-22
EP0648116B1 (fr) 1996-10-09
AU4589393A (en) 1994-01-31
US5585114A (en) 1996-12-17
DE69305346T2 (de) 1997-04-30

Similar Documents

Publication Publication Date Title
DK0648116T3 (da) Sammensætning til kontrolleret frigivelse af et aktivt stof og fremgangsmåde til fremstilling af sådan en sammensætning
FI925845A (fi) Biokeramiskt system foer avgivande av bioaktiva aemnen
DE69412250D1 (de) Pyridobismidazole enthaltendes rigid-rod-Polymer
DE69425671D1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
IL118047A (en) Sulfated oligosaccharides pharmaceutical compositions containing them and preparation of sulfated hexopyranose homooligosaccharides
KR100193014B1 (en) A moisture-curing one-component polysiloxane composition
ATE235503T1 (de) Kohlenhydraten verwendbar in feste verabreichungssysteme
ATE241362T1 (de) Zusammensetzung zur substitutionstherapie, die mindestens ein progestogen und mindestens ein oestrogen enthält
MX9702144A (es) Poliisocianatos que contienen grupos uretidiona y alofanato.
FI970934A (fi) Implantoitava valukappale vaikuttavien aineiden annostelemiseksi kasveihin
DK0648115T3 (da) Præparat til reguleret frigivelse af et aktivt stof og fremgangsmåde til fremstilling af et sådant præparat
FI961535A0 (fi) Vettä sisältäviä polymeraattivalmisteita
NO306667B1 (no) Blandinger for fremming av og opprettholdelse av plantevekst, fremgangsmÕte for deres fremstilling, samt anvendelse herav
JPS6468316A (en) External plaster containing salbutamol
HUT58263A (en) Galacto-mannane derivatives for coating and incorporating pharmaceutical active components
KR930005625A (ko) 생체의 에너지 보급용 당(糖) 및 그 용도
FI961206A (fi) Esteriryhmiä sisältäviä lohkopolyymeerejä vaahdonestoaineina vesisysteemeissä
KR840007658A (ko) 살진균제 조성물
ZA200006476B (en) Biologically active composition.
PE14795A1 (es) Matriz polimerica de policarbonato de etileno y su uso en composiciones farmaceuticas
EP0791599A3 (fr) Procédé pour la stabilisation des halogènures de composés organoétains avec lactames et/ou lactons, et alcoholates de métaux, et compositions pour le revêtement de verre et céramiques